On July 24, 2023, the Board of Directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”) appointed Christopher McCarthy, age 32, as Chief Financial Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Christopher McCarthy was appointed as Chief Financial Officer at INTERPACE BIOSCIENCES, INC..
Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On July 24, 2023, the Board of Directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”) appointed Christopher McCarthy, age 32, as Chief Financial Officer.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.